maria

About maria

This author has not yet filled in any details.
So far maria has created 296 blog entries.

2022 starts with three new scientific publications

CVBF is excited to announce that three new research articles counting with the participation of experts from our consortium, were recently published.  “Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018” analysed and described post-authorization studies (PAS) in the European PAS (EU PAS) register. There is [...]

By |2022-02-28T10:45:27+00:00February 24th, 2022|News|

CVBF is now a member of the European Open Science Cloud

We are happy to announce that CVBF is now a member of the  (EOSC). This will ensure compliance with new Open Science policy in the EU and facilitate the exchange of information among researchers and funders. EOSC is recognised by the Council of the European Union as the pilot action to deepen the new European [...]

By |2022-02-26T15:34:31+00:00February 24th, 2022|News|

EJP RD Training on strategies to foster solutions of undiagnosed rare disease cases

As part of the training activities proposed by EJP RD, an online training course on “Training on strategies to foster solutions of undiagnosed rare disease cases” is being organised by Istituto Superiore di Sanità (ISS) in close collaboration with EJP RD partners. The online event will take place over three days from on April 11th – 13th. Through the presentation of sample use cases that [...]

By |2022-02-03T10:20:54+00:00February 3rd, 2022|News|

Task Force on Disregarded Rare Diseases (Pluto Project)

The Therapies Scientific Committee (TSC) of the International Rare Diseases Research Consortium (IRDiRC) is establishing a Task Force to characterize specific commonalities amongst a large group of “disregarded” rare diseases, with the potential secondary aims to identify removable roadblocks that may foster future research and development. The TSC is specifically looking for members to populate the Task Force with the below expertise in one [...]

By |2022-02-01T09:20:05+00:00February 1st, 2022|News|

Task Force on Drug Repurposing GUIDEBOOK

IRDiRC's Therapies Scientific Committee (TSC) is establishing a Task Force on Drug Repurposing Guidebook aimed at helping developers identify specific tools and practices of relevance for repurposing projects, by focusing on repurposing approaches, following the same successful methodology used for the Orphan Drug Development Guidebook. Interested candidates can submit their application (CV, biosketch and letter of motivation, one paragraph each) to the Scientific Secretariat. [...]

By |2022-02-01T09:14:59+00:00February 1st, 2022|News|

New IRDiRC Publication

The International Rare Diseases Research Consortium (IRDiRC) is proud to announce the publication of a commentary on 10 years of progress and challenges of IRDiRC in the prestigious journal Nature Reviews Drug Discovery. The article summarizes IRDiRC’s vision and goals and highlights its achievements and prospects after its first decade (2011–2021). The commentary has been authored by Lucia Monaco (Consortium Assembly [...]

By |2022-01-27T12:00:36+00:00January 26th, 2022|News|

First paediatric expert patients training workshops: Applications are now opened

  In the framework of the European Joint Programme on Rare Diseases (EJPRD), TEDDY European Network of Excellence for Paediatric Research is organising the first paediatric expert patients training workshops in collaboration with EURORDIS and the Sant Joan de Déu Research Foundation. The workshop is addressed to patients with a chronic rare disease, aged from 12 to 18, interested in the themes of health, [...]

By |2022-01-26T10:03:28+00:00September 29th, 2021|News|

Share4Brain Project’s meeting in Athens

The Share4Brain Project meeting was held on 23-24 of September 2021 at Amarilla hotel in Athens, Greece. Greek policymakers such as MEP Stelios Kymporopoulos, the member of the Hellenic Parliament Mrs Marietta Gianakou, and the mayor of the city of Vouliagmeni Mr Grigoris Konstantellos endorsed the Athens meeting. Partners from Belgium (Belgian Brain Council), Greece (Greek Carers [...]

By |2022-01-26T09:31:38+00:00September 29th, 2021|News|

NeoVanc Project Article published in the LANCET Child & Adolescent Health Journal

The NeoVanc Project article Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial was published in the Lancet Child and Adolescent Health. The article includes the findings of the largest neonatal vancomycin efficacy trial ever conducted: No clear benefit was seen with the use of an optimised short (5±1 [...]

By |2022-01-26T10:11:29+00:00September 28th, 2021|News|

Kids suffer serious adverse reactions in AGTC gene therapy trial

Applied Genetic Technologies Corporation has run into safety problems after escalating the dose in its paediatric gene therapy trial. Sixty percent of subjects in the small high-dose cohort suffered suspected unexpected serious adverse reactions (SUSARs) after being treated for a rare eye disease. The study followed a dose escalation and age de-escalation model, giving progressively higher doses [...]

By |2022-01-26T09:53:54+00:00September 26th, 2021|News|

Newsletter

Sign-up to get the latest news and update information. Don’t worry, we won’t send spam!

Go to Top